Dr. McCreary is a neuropsychopharmacologist, with a recognized track record in drug discovery of novel antiparkinsonian and antipsychotic agents. He has strong industrial experience and is currently neurochemistry and pharmacokinetics Project Leader.

Collaboration: action of serotonin 5-HT1A agonists in models of Parkinson’s disease


Brains Online, Groningen, Pays Bas


Please enable the javascript to submit this form

Follow Neurolixis on: